Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute, shared a post on LinkedIn։
”During my stay in Lisbon I had a privilege to give a lecture for Polish cardiologists about ‘Anticoagulation in specific situations’ during special pre-ACVC event.
Anticoagulation in real life causes lot of dilemmas, and we are increasingly forced to make individualized decisions and move towards patient-oriented precise medicine.
With Christophe Vandenbriele we wrote last year one of the Association for Acute Cardio Vascular Care – ACVC Clinical Decision Making Toolkit chapters: 10.2 Managing anticoagulation in critically ill in specific situations, which includes i.e. bleeding on OAC, anticagulation and hemolysis during MCS, heparin-induced thrombocytopenia, and MV thrombosis.”
Stay updated with Hemostasis Today.
-
Apr 17, 2026, 09:54Andrew Aswani: How NETs Contribute to Disease and Why They Matter
-
Apr 17, 2026, 09:49Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
-
Apr 17, 2026, 09:25The Challanges of Cancer-Associated Thrombosis – ISTH
-
Apr 17, 2026, 08:32Leslie Johns: Our First Low Titer O Whole Blood Products
-
Apr 17, 2026, 08:24Dominique P. Germain: The Critical Role of Cardiac Involvement in Fabry Disease
-
Apr 17, 2026, 07:54Pat Garcia-Gonzalez: Does Having Lifesaving Medicine at a Hospital Guarantee Patient Access?
-
Apr 17, 2026, 05:41Tareq Abadl: Sickle Cell Anemia is Not Just Hemoglobin Deficiency, It’s a Genetic Mutation
-
Apr 17, 2026, 04:58Emmanuel J Favaloro: A Century of von Willebrand Disease – From Discovery to Modern Diagnostic Pathways
-
Apr 17, 2026, 02:41Helena Bradbury: First Haematology EAHAD Supplement of 2026